AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Viemed Healthcare, Inc.

$8.84 +$1.62 (+22.44%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$8.79
Day Range
$8.76$8.98
Year Range
$6.05$12.61
Market Cap
336.7M
AVG Volume
343.63K
Trailing/Forward PE
23.44/16.27
PEG ratio
0.75
Dividend Yield
-
Next Earnings Date
2026-11-04
Primary Exchange
NASDAQUS
Revenue (USD)
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q278.1M
26 Q175.41M
25 Q476.18M
25 Q371.91M
25 Q263.06M
25 Q159.13M
24 Q460.7M
24 Q358M
24 Q254.97M
24 Q150.59M
Net Income (USD)
02M4M6M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q22.76M
26 Q12.58M
25 Q45.64M
25 Q33.51M
25 Q23.16M
25 Q12.62M
24 Q44.32M
24 Q33.88M
24 Q21.47M
24 Q11.6M
Operating Income (USD)
02.5M5M7.5M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q25.06M
26 Q14.73M
25 Q48.66M
25 Q36.12M
25 Q24.51M
25 Q13.84M
24 Q46.45M
24 Q35.63M
24 Q23.62M
24 Q12.2M
EBITDA (USD)
05M10M15M20M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q212.58M
26 Q111.92M
25 Q415.94M
25 Q313.18M
25 Q211.99M
25 Q18.17M
24 Q411.72M
24 Q312.13M
24 Q29.38M
24 Q18.56M
Cash Flows (USD)
-20M-10M010M20M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q27.44M
26 Q11.36M
25 Q49.7M
25 Q310.73M
25 Q24.12M
25 Q1-12.63M
24 Q43.16M
24 Q31.74M
24 Q21.25M
24 Q1-4.83M
EPS (USD)
00.050.10.1524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.07
26 Q10.06
25 Q40.14
25 Q30.09
25 Q20.08
25 Q10.06
24 Q40.1
24 Q30.1
24 Q20.04
24 Q10.04
Expenses (USD)
020M40M60MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q248.13M
26 Q142.08M
25 Q443.85M
25 Q342.51M
25 Q240.07M
25 Q147.02M
24 Q442.36M
24 Q340.14M
24 Q237.81M
24 Q133M
Cash & Debt (USD)
010M20M30MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q210.68M
26 Q19.76M
25 Q413.5M
25 Q311.12M
25 Q220.02M
25 Q110.16M
24 Q417.54M
24 Q311.35M
24 Q28.81M
24 Q17.31M
Debt ratios
-0.4-0.200.20.424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Debt ratios by quarter
PeriodDebt ratios
26 Q20.02
26 Q10.05
25 Q40.05
25 Q30.3
25 Q2-0.3
25 Q1-0.08
24 Q4-0.26
24 Q3-0.1
24 Q20.09
24 Q10.06
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Margins by quarter
PeriodMargins
26 Q257.19%
26 Q156.27%
25 Q457.89%
25 Q357.49%
25 Q257.69%
25 Q156.28%
24 Q459.54%
24 Q359.26%
24 Q259.84%
24 Q158.91%
Return on Capital
0%1%2%3%4%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Return on Capital by quarter
PeriodReturn on Capital
26 Q21.89%
26 Q11.77%
25 Q43.93%
25 Q32.59%
25 Q22.23%
25 Q11.92%
24 Q43.24%
24 Q33.06%
24 Q21.21%
24 Q11.38%
Shares Outstanding
010M20M30M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Shares Outstanding by quarter
PeriodShares Outstanding
26 Q238.25M
26 Q138.43M
25 Q438.02M
25 Q338.64M
25 Q239.52M
25 Q139.43M
24 Q439.03M
24 Q338.87M
24 Q238.82M
24 Q138.72M
Book Value Per Share (USD)
0123424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q23.82
26 Q13.79
25 Q43.78
25 Q33.51
25 Q23.58
25 Q13.47
24 Q43.42
24 Q33.26
24 Q23.12
24 Q13
Total Assets (USD)
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
VMD Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q2204.22M
26 Q1197.36M
25 Q4214.94M
25 Q3202.36M
25 Q2184.6M
25 Q1178.08M
24 Q4177.07M
24 Q3169.53M
24 Q2163.95M
24 Q1154.88M
Employee Count
05001K1.5K2019202020212022202320242025
VMD Employee Count by quarter
PeriodEmployee Count
20251.38K
20241.18K
2023996
2022743
2021627
2020511
2019418
PE Ratio
152025303540med 23.46Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VMD PE Ratio by quarter
PeriodPE Ratio
Sep 2623.32
Sep 2623.19
Sep 2623.95
Aug 2623.27
Aug 2623.35
Aug 2624.27
Aug 2625.67
Jul 2630.12
Jul 2630.37
Jul 2631.36
Jul 2631.77
Jul 2631.02
Jun 2630.01
Jun 2627.46
Jun 2626.97
Jun 2625.73
May 2625.39
May 2624.9
May 2624.13
May 2623.07
May 2625.38
Apr 2624.59
Apr 2624.8
Apr 2624.21
Apr 2624.52
Mar 2623.55
Mar 2622.17
Mar 2623.42
Mar 2622.35
Feb 2624.7
Feb 2623.39
Feb 2623.51
Feb 2624.53
Jan 2621.77
Jan 2620.78
Jan 2620.81
Jan 2620.55
Jan 2620.5
Dec 2520.72
Dec 2521.06
Dec 2520.5
Dec 2519.22
Nov 2519.62
Nov 2518.91
Nov 2518.14
Nov 2518.08
Oct 2518.26
Oct 2519.57
Oct 2518.83
Oct 2519.28
Oct 2519.59
Sep 2518.97
Sep 2519.03
Sep 2519.17
Sep 2519.45
Aug 2520.84
Aug 2520.67
Aug 2519.48
Aug 2520.07
Aug 2519.03
Jul 2519.64
Jul 2520.83
Jul 2521.63
Jul 2522.94
Jun 2522.21
Jun 2521.24
Jun 2521.34
Jun 2521.56
May 2521.34
May 2520.6
May 2521.69
May 2520.28
May 2525.53
Apr 2524.49
Apr 2522.97
Apr 2522.9
Apr 2523.84
Mar 2525.19
Mar 2525.08
Mar 2526.23
Mar 2527.96
Feb 2529.23
Feb 2529.01
Feb 2529.19
Feb 2529.71
Jan 2530.53
Jan 2531.62
Jan 2530.39
Jan 2529.64
Jan 2530.27
Dec 2430.42
Dec 2429.75
Dec 2432.58
Dec 2432.14
Nov 2432.32
Nov 2432.62
Nov 2433
Nov 2433.82
Nov 2435.31
Oct 2437.89
Free Cash Flow Yield
-5%0%5%10%med 1.16%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VMD Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 268.65%
Sep 268.7%
Sep 268.42%
Aug 268.67%
Aug 268.64%
Aug 268.31%
Aug 267.86%
Jul 265.78%
Jul 265.73%
Jul 265.55%
Jul 265.48%
Jul 265.61%
Jun 265.8%
Jun 266.34%
Jun 266.45%
Jun 266.77%
May 266.85%
May 266.99%
May 267.21%
May 267.54%
May 263.15%
Apr 263.25%
Apr 263.22%
Apr 263.3%
Apr 263.26%
Mar 263.39%
Mar 263.6%
Mar 263.41%
Mar 263.57%
Feb 261.6%
Feb 261.69%
Feb 261.68%
Feb 261.61%
Jan 261.82%
Jan 261.9%
Jan 261.9%
Jan 261.92%
Jan 261.93%
Dec 251.91%
Dec 251.88%
Dec 251.93%
Dec 252.06%
Nov 252.02%
Nov 252.09%
Nov 252.18%
Nov 252.19%
Oct 25-1.41%
Oct 25-1.32%
Oct 25-1.37%
Oct 25-1.34%
Oct 25-1.32%
Sep 25-1.36%
Sep 25-1.35%
Sep 25-1.34%
Sep 25-1.33%
Aug 25-1.24%
Aug 25-1.25%
Aug 25-1.32%
Aug 25-1.28%
Aug 25-2.77%
Jul 25-2.69%
Jul 25-2.53%
Jul 25-2.44%
Jul 25-2.3%
Jun 25-2.38%
Jun 25-2.48%
Jun 25-2.47%
Jun 25-2.45%
May 25-2.47%
May 25-2.56%
May 25-2.43%
May 25-2.6%
May 250.46%
Apr 250.48%
Apr 250.51%
Apr 250.51%
Apr 250.49%
Mar 250.46%
Mar 250.47%
Mar 250.45%
Mar 251.2%
Feb 251.15%
Feb 251.16%
Feb 251.15%
Feb 251.13%
Jan 251.1%
Jan 251.07%
Jan 251.11%
Jan 251.14%
Jan 251.11%
Dec 241.11%
Dec 241.13%
Dec 241.03%
Dec 241.05%
Nov 241.04%
Nov 241.03%
Nov 241.02%
Nov 241%
Nov 242.45%
Oct 242.28%
Price to Sales
0.811.21.41.61.8med 1.23Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VMD Price to Sales by quarter
PeriodPrice to Sales
Sep 261.12
Sep 261.11
Sep 261.15
Aug 261.12
Aug 261.12
Aug 261.17
Aug 261.23
Jul 261.56
Jul 261.58
Jul 261.63
Jul 261.65
Jul 261.61
Jun 261.56
Jun 261.43
Jun 261.4
Jun 261.34
May 261.32
May 261.29
May 261.25
May 261.2
May 261.4
Apr 261.36
Apr 261.37
Apr 261.34
Apr 261.35
Mar 261.3
Mar 261.23
Mar 261.29
Mar 261.24
Feb 261.32
Feb 261.25
Feb 261.26
Feb 261.31
Jan 261.16
Jan 261.11
Jan 261.11
Jan 261.1
Jan 261.09
Dec 251.11
Dec 251.13
Dec 251.09
Dec 251.03
Nov 251.05
Nov 251.01
Nov 250.97
Nov 250.97
Oct 251.06
Oct 251.14
Oct 251.09
Oct 251.12
Oct 251.14
Sep 251.1
Sep 251.1
Sep 251.11
Sep 251.13
Aug 251.21
Aug 251.2
Aug 251.13
Aug 251.16
Aug 251
Jul 251.04
Jul 251.1
Jul 251.14
Jul 251.21
Jun 251.17
Jun 251.12
Jun 251.13
Jun 251.14
May 251.13
May 251.09
May 251.14
May 251.07
May 251.28
Apr 251.23
Apr 251.15
Apr 251.15
Apr 251.2
Mar 251.27
Mar 251.26
Mar 251.32
Mar 251.36
Feb 251.42
Feb 251.41
Feb 251.42
Feb 251.45
Jan 251.49
Jan 251.54
Jan 251.48
Jan 251.44
Jan 251.47
Dec 241.48
Dec 241.45
Dec 241.59
Dec 241.56
Nov 241.57
Nov 241.59
Nov 241.61
Nov 241.65
Nov 241.63
Oct 241.74
EV/EBITDA
5678910med 6.65Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VMD EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 266.32
Sep 266.29
Sep 266.49
Aug 266.31
Aug 266.33
Aug 266.58
Aug 266.96
Jul 268.51
Jul 268.58
Jul 268.86
Jul 268.97
Jul 268.76
Jun 268.48
Jun 267.76
Jun 267.62
Jun 267.28
May 267.18
May 267.04
May 266.83
May 266.53
May 267.74
Apr 267.5
Apr 267.56
Apr 267.39
Apr 267.48
Mar 267.19
Mar 266.77
Mar 267.15
Mar 266.82
Feb 267.76
Feb 267.37
Feb 267.4
Feb 267.71
Jan 266.88
Jan 266.58
Jan 266.59
Jan 266.51
Jan 266.49
Dec 256.56
Dec 256.66
Dec 256.49
Dec 256.11
Nov 256.23
Nov 256.01
Nov 255.78
Nov 255.76
Oct 255.5
Oct 255.91
Oct 255.68
Oct 255.82
Oct 255.92
Sep 255.73
Sep 255.74
Sep 255.79
Sep 255.88
Aug 256.32
Aug 256.26
Aug 255.89
Aug 256.08
Aug 255.56
Jul 255.75
Jul 256.1
Jul 256.34
Jul 256.73
Jun 256.51
Jun 256.22
Jun 256.25
Jun 256.32
May 256.25
May 256.03
May 256.35
May 255.94
May 256.63
Apr 256.35
Apr 255.94
Apr 255.92
Apr 256.17
Mar 256.53
Mar 256.51
Mar 256.81
Mar 256.96
Feb 257.28
Feb 257.22
Feb 257.27
Feb 257.4
Jan 257.61
Jan 257.88
Jan 257.57
Jan 257.38
Jan 257.54
Dec 247.58
Dec 247.41
Dec 248.12
Dec 248.01
Nov 248.06
Nov 248.13
Nov 248.23
Nov 248.43
Nov 248.53
Oct 249.14
Price/Operating Cashflow
46810med 6.61Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VMD Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 265.56
Sep 265.53
Sep 265.71
Aug 265.55
Aug 265.57
Aug 265.79
Aug 266.12
Jul 267.85
Jul 267.92
Jul 268.17
Jul 268.28
Jul 268.08
Jun 267.82
Jun 267.16
Jun 267.03
Jun 266.71
May 266.62
May 266.49
May 266.29
May 266.01
May 267.3
Apr 267.07
Apr 267.13
Apr 266.96
Apr 267.05
Mar 266.77
Mar 266.38
Mar 266.74
Mar 266.43
Feb 266.94
Feb 266.57
Feb 266.6
Feb 266.89
Jan 266.12
Jan 265.84
Jan 265.84
Jan 265.77
Jan 265.76
Dec 255.82
Dec 255.92
Dec 255.76
Dec 255.4
Nov 255.51
Nov 255.31
Nov 255.09
Nov 255.08
Oct 255.96
Oct 256.38
Oct 256.14
Oct 256.29
Oct 256.39
Sep 256.19
Sep 256.21
Sep 256.25
Sep 256.35
Aug 256.8
Aug 256.74
Aug 256.36
Aug 256.55
Aug 255.73
Jul 255.92
Jul 256.28
Jul 256.52
Jul 256.91
Jun 256.69
Jun 256.4
Jun 256.43
Jun 256.5
May 256.43
May 256.21
May 256.54
May 256.11
May 257.36
Apr 257.06
Apr 256.62
Apr 256.6
Apr 256.87
Mar 257.26
Mar 257.23
Mar 257.56
Mar 257.8
Feb 258.15
Feb 258.09
Feb 258.14
Feb 258.29
Jan 258.52
Jan 258.82
Jan 258.47
Jan 258.27
Jan 258.44
Dec 248.48
Dec 248.3
Dec 249.09
Dec 248.96
Nov 249.01
Nov 249.1
Nov 249.2
Nov 249.43
Nov 248.69
Oct 249.33
Price to Book
1.522.533.5med 2.31Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VMD Price to Book by quarter
PeriodPrice to Book
Sep 262.32
Sep 262.3
Sep 262.38
Aug 262.31
Aug 262.32
Aug 262.41
Aug 262.55
Jul 263.08
Jul 263.1
Jul 263.2
Jul 263.24
Jul 263.17
Jun 263.07
Jun 262.8
Jun 262.75
Jun 262.63
May 262.59
May 262.54
May 262.46
May 262.36
May 262.64
Apr 262.56
Apr 262.58
Apr 262.52
Apr 262.55
Mar 262.45
Mar 262.31
Mar 262.44
Mar 262.33
Feb 262.48
Feb 262.35
Feb 262.36
Feb 262.46
Jan 262.19
Jan 262.09
Jan 262.09
Jan 262.06
Jan 262.06
Dec 252.08
Dec 252.12
Dec 252.06
Dec 251.93
Nov 251.97
Nov 251.9
Nov 251.82
Nov 251.82
Oct 251.8
Oct 251.93
Oct 251.86
Oct 251.9
Oct 251.93
Sep 251.87
Sep 251.88
Sep 251.89
Sep 251.92
Aug 252.06
Aug 252.04
Aug 251.92
Aug 251.98
Aug 251.71
Jul 251.76
Jul 251.87
Jul 251.94
Jul 252.06
Jun 252
Jun 251.91
Jun 251.92
Jun 251.94
May 251.92
May 251.85
May 251.95
May 251.82
May 252.16
Apr 252.07
Apr 251.94
Apr 251.94
Apr 252.01
Mar 252.13
Mar 252.12
Mar 252.22
Mar 252.3
Feb 252.4
Feb 252.39
Feb 252.4
Feb 252.44
Jan 252.51
Jan 252.6
Jan 252.5
Jan 252.44
Jan 252.49
Dec 242.5
Dec 242.45
Dec 242.68
Dec 242.64
Nov 242.66
Nov 242.68
Nov 242.71
Nov 242.78
Nov 242.76
Oct 242.96
Viemed Healthcare, Inc.
VMD
Stockpicker

Video analysis: VMD

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: VMD

Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands

marketbeat.com · 29 Aug 2026

Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands

Viemed Healthcare NASDAQ: VMD outlined its growth strategy, product diversification and capital allocation priorities at the Midwest IDEAS Conference, emphasizing its focus on providing in-home care for patients with complex respiratory conditions.

Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript

seekingalpha.com · 4 Aug 2026

Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript

Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript

Viemed Healthcare Q2 Earnings Call Highlights

marketbeat.com · 4 Aug 2026

Viemed Healthcare Q2 Earnings Call Highlights

Viemed Healthcare NASDAQ: VMD reported record second-quarter revenue as growth in its ventilator business resumed under the updated Medicare coverage framework and newer service lines expanded.

Viemed Healthcare, Inc. (VMD) Lags Q2 Earnings Estimates

zacks.com · 3 Aug 2026

Viemed Healthcare, Inc. (VMD) Lags Q2 Earnings Estimates

Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.08 per share a year ago.

Viemed Healthcare Announces Second Quarter 2026 Financial Results

accessnewswire.com · 3 Aug 2026

Viemed Healthcare Announces Second Quarter 2026 Financial Results

LAFAYETTE, LA / ACCESS Newswire / August 3, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three and six months ended June 30, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended June 30, 2026 were $78.1 million, setting a Company record, representing an increase of $15.0 million, or 23.9%, compared with the prior-year quarter and an increase of approximately 3.6% sequentially.

Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details

accessnewswire.com · 21 Jul 2026

Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / July 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Second Quarter 2026 Earnings Conference Call on Tuesday, August 4, 2026, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=peVp8cbE Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.